Advertisement
Screener

BRUKER CORPORATION (BRKR) Sales Revenue, Goods, Net (Deprecated 2018-01-31)

2.8 / 5 stars · 68/120 Roast Me

BRUKER CORPORATION Sales Revenue, Goods, Net (Deprecated 2018-01-31)

BRUKER CORPORATION (BRKR) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $1.48 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SalesRevenueGoodsNet · last filed 2018-03-16

  • BRUKER CORPORATION sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $450.30M, a 12.77% increase year-over-year.
  • BRUKER CORPORATION sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $364.40M, a 11.03% increase year-over-year.
  • BRUKER CORPORATION sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $345.90M, a 13.19% increase year-over-year.
  • BRUKER CORPORATION sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $318.90M, a 2.11% increase year-over-year.
  • BRUKER CORPORATION sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $1.48B, a 9.97% increase from fiscal 2016.
  • BRUKER CORPORATION sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $1.35B, a 2.58% decline from fiscal 2015.
  • BRUKER CORPORATION sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $1.38B, a 12.14% decline from fiscal 2014.
  • BRUKER CORPORATION sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $1.57B, a 2.45% decline from fiscal 2013.
Period endSales Revenue, Goods, Net (Deprecated 2018-01-31) 3 monthSales Revenue, Goods, Net (Deprecated 2018-01-31) 6 monthSales Revenue, Goods, Net (Deprecated 2018-01-31) 9 monthSales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month
2017-12-31$450.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$814.70M
derived: sum of 2 quarters · filed 2018-03-16
$1.16B
derived: sum of 3 quarters · filed 2018-03-16
$1.48B
10-K · filed 2018-03-16
2017-09-30$364.40M
10-Q · filed 2017-11-09
$710.30M
derived: sum of 2 quarters · filed 2017-11-09
$1.03B
10-Q · filed 2017-11-09
$1.43B
derived: sum of 4 quarters · filed 2018-03-16
2017-06-30$345.90M
10-Q · filed 2017-08-09
$664.80M
10-Q · filed 2017-08-09
$1.06B
derived: sum of 3 quarters · filed 2018-03-16
$1.39B
derived: sum of 4 quarters · filed 2018-03-16
2017-03-31$318.90M
10-Q · filed 2017-05-10
$718.20M
derived: sum of 2 quarters · filed 2018-03-16
$1.05B
derived: sum of 3 quarters · filed 2018-03-16
$1.35B
derived: sum of 4 quarters · filed 2018-03-16
2016-12-31$399.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$727.50M
derived: sum of 2 quarters · filed 2018-03-16
$1.03B
derived: sum of 3 quarters · filed 2018-03-16
$1.35B
10-K · filed 2018-03-16
2016-09-30$328.20M
10-Q · filed 2017-11-09
$633.80M
derived: sum of 2 quarters · filed 2017-11-09
$946.10M
10-Q · filed 2017-11-09
$1.36B
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30$305.60M
10-Q · filed 2017-08-09
$617.90M
10-Q · filed 2017-08-09
$1.03B
derived: sum of 3 quarters · filed 2018-03-16
$1.36B
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31$312.30M
10-Q · filed 2017-05-10
$724.60M
derived: sum of 2 quarters · filed 2018-03-16
$1.06B
derived: sum of 3 quarters · filed 2018-03-16
$1.40B
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31$412.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$746.90M
derived: sum of 2 quarters · filed 2018-03-16
$1.08B
derived: sum of 3 quarters · filed 2018-03-16
$1.38B
10-K · filed 2018-03-16
2015-09-30$334.60M
10-Q · filed 2016-11-09
$670.80M
derived: sum of 2 quarters · filed 2016-11-09
$968.80M
10-Q · filed 2016-11-09
$1.41B
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$336.20M
10-Q · filed 2016-08-05
$634.20M
10-Q · filed 2016-08-05
$1.08B
derived: sum of 3 quarters · filed 2017-03-01
$1.44B
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$298.00M
10-Q · filed 2016-05-06
$742.70M
derived: sum of 2 quarters · filed 2017-03-01
$1.10B
derived: sum of 3 quarters · filed 2017-03-01
$1.50B
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$444.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$806.90M
derived: sum of 2 quarters · filed 2017-03-01
$1.21B
derived: sum of 3 quarters · filed 2017-03-01
$1.57B
10-K · filed 2017-03-01
2014-09-30$362.20M
10-Q · filed 2015-11-06
$761.10M
derived: sum of 2 quarters · filed 2015-11-06
$1.13B
10-Q · filed 2015-11-06
$1.62B
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$398.90M
10-Q · filed 2015-08-07
$765.00M
10-Q · filed 2015-08-07
$1.26B
derived: sum of 3 quarters · filed 2016-02-29
$1.64B
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$366.10M
10-Q · filed 2015-05-08
$857.60M
derived: sum of 2 quarters · filed 2016-02-29
$1.24B
derived: sum of 3 quarters · filed 2016-02-29
$1.64B
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$491.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$876.50M
derived: sum of 2 quarters · filed 2016-02-29
$1.27B
derived: sum of 3 quarters · filed 2016-02-29
$1.61B
10-K · filed 2016-02-29
2013-09-30$385.00M
10-Q · filed 2014-11-07
$780.60M
derived: sum of 2 quarters · filed 2014-11-07
$1.12B
10-Q · filed 2014-11-07
$1.58B
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$395.60M
10-Q · filed 2014-08-08
$734.90M
10-Q · filed 2014-08-08
$1.19B
derived: sum of 3 quarters · filed 2015-02-27
$1.57B
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$339.30M
10-Q · filed 2014-05-09
$794.80M
derived: sum of 2 quarters · filed 2015-02-27
$1.17B
derived: sum of 3 quarters · filed 2015-02-27
$1.54B
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$455.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$834.10M
derived: sum of 2 quarters · filed 2015-02-27
$1.20B
derived: sum of 3 quarters · filed 2015-02-27
$1.56B
10-K · filed 2015-02-27
2012-09-30$378.60M
10-Q · filed 2013-11-08
$749.20M
derived: sum of 2 quarters · filed 2013-11-08
$1.10B
10-Q · filed 2013-11-08
$1.52B
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30$370.60M
10-Q · filed 2013-08-08
$722.40M
10-Q · filed 2013-08-08
$1.14B
derived: sum of 3 quarters · filed 2014-02-27
$1.50B
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31$351.80M
10-Q · filed 2013-05-09
$766.70M
derived: sum of 2 quarters · filed 2014-02-27
$1.13B
derived: sum of 3 quarters · filed 2014-02-27
$1.49B
derived: sum of 4 quarters · filed 2014-02-27
2011-12-31$414.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
$781.40M
derived: sum of 2 quarters · filed 2014-02-27
$1.13B
derived: sum of 3 quarters · filed 2014-02-27
$1.45B
10-K · filed 2014-02-27
2011-09-30$366.50M
10-Q · filed 2012-11-08
$718.60M
derived: sum of 2 quarters · filed 2012-11-08
$1.03B
10-Q · filed 2012-11-08
$1.40B
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$352.10M
10-Q · filed 2012-08-09
$664.20M
10-Q · filed 2012-08-09
$1.03B
derived: sum of 3 quarters · filed 2013-02-28
$1.30B
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31$312.10M
10-Q · filed 2012-05-09
$676.80M
derived: sum of 2 quarters · filed 2013-02-28
$946.50M
derived: sum of 3 quarters · filed 2013-02-28
$1.21B
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31$364.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$634.40M
derived: sum of 2 quarters · filed 2013-02-28
$901.40M
derived: sum of 3 quarters · filed 2013-02-28
$1.15B
10-K · filed 2013-02-28
2010-09-30$269.70M
10-Q · filed 2011-11-09
$536.70M
derived: sum of 2 quarters · filed 2011-11-09
$780.70M
10-Q · filed 2011-11-09
2010-06-30$267.00M
10-Q · filed 2011-08-09
$511.00M
10-Q · filed 2011-08-09
2010-03-31$244.00M
10-Q · filed 2011-05-09
2009-12-31$985.30M
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34